Case Conference June 6th 2012
06-Jun-2012, Divisi Ginekologi Onkologi RSCM Case Conference
June 6th 2012
Resume
Ms. W, 18 yo
359-66-79, Jamkesda
Patient post laparotomy suboptimal debulking at Karawaci Hospital at November 2011 with post-op diagnosis: ovarian cancer st III C. PA result was Germ cell tumor, yolk sac type/endoderm sinus, with invasion to omentum, chronic appendicitis with acute exacerbation.
First came to RSCM on December 2011 with chief complain anuria since 1 week, Renal US was done and the result was bilateral hydronephrosis and solid mass in abdominal cavity.
Performed bilateral nefrostomy ( 5/12/2011)
BEP chemotherapy was done from December 2011 until February 2012.
BEP seri : 15th December 2011
25th January 2012
17th February 2012
Marriage history: not married yet
PA (1109841) result: Sinus endodermal tumor
Laboratoy (5/3/2012) :
Tumor marker
Pre-chemo : AFP : 54.390 à 347,5
LDH: 2.203 à 647
Ca-125 : 114,1 à 12,8
US examination (08/03/2012):
Conclusion:
Right hydronephrosis, minimal right pleural efussion,
Mass shrinken (61x47 mm) compaed to US exam on 12 Des 2011 (190x96 mm).
Ro Thorax : No abnormalty at lung and heart.
Consult to Pulmonology : Low risk
Consult to Anesthesia : ASA II
23/04/2012
Performed Laparotomy with operation procedure : Secondary debulking, debulking of tumor (Salpingoophorectomy sinistra), Total Omentectomy, with residu from ileum 4 x 4 x 1 cm and rectum 5 x 4 x 0,5 cm.
PA Result ( 24/4/2012 ) :
Histologycally correspond with endodermal sinus (residu?) to the tissue : left tumor, implant on bowel and rectum
USG ( May 25th 2012 )
Left adnexa with lobulated solid lesion size 19,8 x 10,6 x 17,6 cm suspected residif. No metastatic lesion in liver and lien.
Solid lesion on paraaorta size 6 cm suspected lymph node enlargement
Left renal with hydronephrosis grade I
No pleural effusion. Ascites (+).
May 28th 2012 à 4th chemotherapy (BEP), but during chemotherapy the patient went home by her own will
A/ Ovarian cancer residif post chemotherapy and suboptimal debulking
P/ Palliative care :
è 1. Length of life with chemotherapy
or
è 2. Quality of life
Berita Lainnya
13-Mar-2013,Divisi Ginekologi Onkologi RSCMCase Conference March 13th 2013

Case Conference March 13th 2013

Case Conference March 6th 2013

Case Conference March 6th 2013

Case Conference February 20th 2013

Case Conference February 113th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

